Cargando…
Targeting MTA1/HIF‐1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression
The metastasis‐associated protein 1(MTA1)/histone deacetylase (HDAC) unit is a cancer progression‐related epigenetic regulator, which is overexpressed in hormone‐refractory and metastatic prostate cancer (PCa). In our previous studies, we found a significantly increased MTA1 expression in a prostate...
Autores principales: | Butt, Nasir A., Kumar, Avinash, Dhar, Swati, Rimando, Agnes M., Akhtar, Israh, Hancock, John C., Lage, Janice M., Pound, Charles R., Lewin, Jack R., Gomez, Christian R., Levenson, Anait S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673954/ https://www.ncbi.nlm.nih.gov/pubmed/29024573 http://dx.doi.org/10.1002/cam4.1209 |
Ejemplares similares
-
Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer
por: Dhar, Swati, et al.
Publicado: (2016) -
Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer
por: Dhar, Swati, et al.
Publicado: (2015) -
MTA1 drives malignant progression and bone metastasis in prostate cancer
por: Kumar, Avinash, et al.
Publicado: (2018) -
Pterostilbene Acts through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate Cancer
por: Li, Kun, et al.
Publicado: (2013) -
MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer
por: Kumar, Avinash, et al.
Publicado: (2019)